Ovarian Cancer

Study Reports Improved Outcomes With Olaparib Maintenance in Ovarian Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date April 19, 2021

A team of investigators conducted a double-blind, placebo-controlled, phase 3 trial to assess outcomes following olaparib treatment in patients with BRCA 1/2-mutated, relapsed ovarian cancer.

Most Patients With Breast, Ovarian Cancer Do Not Undergo Genetic Testing

By

Christina Bennett, MS

Publish Date March 2, 2021

The number of genes tested for ovarian and breast cancer has grown, but most patients do not undergo testing, and variant-of-unknown-significance results are common, especially among minority populations.

Oral Contraceptives Protect Against Ovarian, Endometrial Cancer

Publish Date December 29, 2020

Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives.

Is There a Survival Benefit for Patients with Advanced Ovarian Clear Cell Carcinoma Who Complete More Than 6 Cycles of Postoperative Chemotherapy?

By

Rick Maffei

Publish Date December 25, 2020

[Cancer Management and Research] Retrospective review sought to determine how residual tumor diameter and number of cycles of adjuvant chemotherapy after surgery influenced prognosis for patients with OCCC.

Use of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Has Doubled

By

Leah Lawrence

Publish Date October 2, 2020

Use of neoadjuvant chemotherapy for patients with stage IIIC and IV epithelial ovarian cancer has increased from 2004 to 2016.

Ovarian Cancer Clinical Trials

Clinical Trial: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Clinical Trial: Prophylactic Salpingectomy With Delayed Oophorectomy

Clinical Trial: Interactive Educational Website for Women With Ovarian Cancer & Caregivers

Clinical Trial: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Clinical Trial: AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer